203 related articles for article (PubMed ID: 19289653)
1. Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome.
Stewart JM; Ocon AJ; Clarke D; Taneja I; Medow MS
Hypertension; 2009 May; 53(5):767-74. PubMed ID: 19289653
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.
Stewart JM; Taneja I; Glover J; Medow MS
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H466-73. PubMed ID: 17993594
[TBL] [Abstract][Full Text] [Related]
3. Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response.
Stewart JM; Taneja I; Raghunath N; Clarke D; Medow MS
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H327-34. PubMed ID: 18469148
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous constitutive nitric oxide synthase activation in postural tachycardia syndrome with splanchnic hyperemia.
Stewart JM; Nafday A; Ocon AJ; Terilli C; Medow MS
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H704-11. PubMed ID: 21642500
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 1 receptor blockade restores angiotensin-(1-7)-induced coronary vasodilation in hypertrophic rat hearts.
Souza ÁP; Sobrinho DB; Almeida JF; Alves GM; Macedo LM; Porto JE; Vêncio EF; Colugnati DB; Santos RA; Ferreira AJ; Mendes EP; Castro CH
Clin Sci (Lond); 2013 Nov; 125(9):449-59. PubMed ID: 23718715
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome.
Stewart JM; Medow MS; Minson CT; Taneja I
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2161-7. PubMed ID: 17660395
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
8. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
[TBL] [Abstract][Full Text] [Related]
9. Losartan attenuates modest but not strong renal vasoconstriction induced by nitric oxide inhibition.
Turkstra E; Braam B; Koomans HA
J Cardiovasc Pharmacol; 1998 Oct; 32(4):593-600. PubMed ID: 9781927
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats.
Jessup JA; Gallagher PE; Averill DB; Brosnihan KB; Tallant EA; Chappell MC; Ferrario CM
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2166-72. PubMed ID: 16766648
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of angiotensin regulation in postural tachycardia syndrome.
Mustafa HI; Garland EM; Biaggioni I; Black BK; Dupont WD; Robertson D; Raj SR
Heart Rhythm; 2011 Mar; 8(3):422-8. PubMed ID: 21266211
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):758-65. PubMed ID: 21252069
[TBL] [Abstract][Full Text] [Related]
14. ACE2: more of Ang-(1-7) or less Ang II?
Ferrario CM
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):1-6. PubMed ID: 21045683
[TBL] [Abstract][Full Text] [Related]
15. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes.
Gallagher PE; Chappell MC; Ferrario CM; Tallant EA
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C420-6. PubMed ID: 16176966
[TBL] [Abstract][Full Text] [Related]
17. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II relaxations of bovine adrenal cortical arteries: role of angiotensin II metabolites and endothelial nitric oxide.
Gauthier KM; Zhang DX; Cui L; Nithipatikom K; Campbell WB
Hypertension; 2008 Jul; 52(1):150-5. PubMed ID: 18490519
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator Effect of Angiotensin-(1-7) on Vascular Coronary Bed of Rats: Role of Mas, ACE and ACE2.
de Moraes PL; Kangussu LM; Castro CH; Almeida AP; Santos RAS; Ferreira AJ
Protein Pept Lett; 2017 Nov; 24(9):869-875. PubMed ID: 28758595
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Yousif MH; Dhaunsi GS; Makki BM; Qabazard BA; Akhtar S; Benter IF
Pharmacol Res; 2012 Sep; 66(3):269-75. PubMed ID: 22580236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
